, Volume 37, Issue 1, pp 97–104 | Cite as

Acute Upper Gastrointestinal Bleeding

  • John A. Schaffner
Practical Therapeutic


The treatment of acute upper gastrointestinal bleeding is becoming more dependent upon early diagnosis. For the majority of patients whose bleeding has stopped when they come to the physician’s attention, treatment for peptic disorders remains the mainstay of therapy. For patients who present to the physician actively bleeding, early intervention with endoscopic therapeutic techniques probably will be the most beneficial. Currently available pharmacotherapeutic agents are of limited value in this situation. Further studies to prove and confirm the efficacy of the various techniques need to be carried out.


Cimetidine Vasopressin Gastrointestinal Bleeding Tranexamic Acid Sucralfate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Barer D, Ogilvie A, Henry D, et al. Cimetidine and tranexamic acid in the treatment of acute upper gastrointestinal tract bleeding. New England Journal of Medicine 308: 1571–1575, 1983PubMedCrossRefGoogle Scholar
  2. Booker JA, Johnston M, Booker CI, Tydd T, Mitchell R. Prognostic factors for continued or rebleeding and death from gastrointestinal haemorrhage in the elderly. Age and Ageing 16: 208–214, 1987PubMedCrossRefGoogle Scholar
  3. Cannon LA, Heiselman D, Gardner W, Jones J. Prophylaxis of upper gastrointestinal tract bleeding in mechanically ventilated patients. Archives of Internal Medicine 147: 2101–2106, 1987PubMedCrossRefGoogle Scholar
  4. Cello JP, Grendell JH, Crass RA, et al. Endoscopic sclerotherapy versus portacaval shunt in patients with severe cirrhosis and variceal hemorrhage. New England Journal of Medicine 311: 1589–1593, 1984PubMedCrossRefGoogle Scholar
  5. Christiansen J, Yotis A. The role of somatostatin and a long-acting analogue, SMS 201-995, in acute bleeding due to peptic ulceration. Scandinavian Journal of Gastroenterology 21 (Suppl. 119): 109–114, 1986CrossRefGoogle Scholar
  6. Collins R, Langman M. Treatment with histamine H2antagonists in acute upper gastrointestinal hemorrhage: implications of randomized trials. New England Journal of Medicine 313: 660–666, 1985PubMedCrossRefGoogle Scholar
  7. Donowitz LG, Page MC, Mileur BL, Guenthner SH. Alteration of normal gastric flora in critical care patients receiving antacid and cimetidine therapy. Infection Control 7: 23–26, 1986PubMedGoogle Scholar
  8. Driks MR, Craven DE, Celli BR, et al. Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers. New England Journal of Medicine 317: 1376–1382, 1987PubMedCrossRefGoogle Scholar
  9. Eckstein MR, Kelemouridis V, Athanasoulis CA, Waltman AC, Feldman L, et al. Gastric bleeding: therapy with intraarterial vasopressin and transcatheter embolization. Radiology 152: 643–646, 1984PubMedGoogle Scholar
  10. Fleischer D. Endoscopic therapy of upper gastrointestinal bleeding in humans. Gastroenterology 90: 217–234, 1986PubMedGoogle Scholar
  11. Fogel MR, Knauer CM, Andres LL, Mahal AS, et al. Continuous intravenous vasopressin in acute upper gastrointestinal bleeding. Annals of Internal Medicine 96: 565–569, 1982.PubMedGoogle Scholar
  12. Freeman JG, Cobden I, Lishman AH, Record CO. Controlled trial of terlipressin (‘glypressin’) versus vasopressin in the early treatment of esophageal varices. Lancet 2: 66–68, 1982PubMedCrossRefGoogle Scholar
  13. Gandhii GM. Intraperitoneal and intragastric norepinephrine instillation in massive gastrointestinal bleeding: clinical study. American Journal of Gastroenterology 76: 42–48, 1976Google Scholar
  14. Gomes AS, Lois JF, McCoy RD. Angiographie treatment of gastrointestinal hemorrhage: comparison of vasopressin infusion and embolization. American Journal of Roentgenology 146: 1031–1037, 1986PubMedGoogle Scholar
  15. Groszmann RJ, Kravetz D, Bosch J, Glickman M, et al. Nitroglycerin improves the hemodynamic response to vasopressin in portal hypertension. Hepatology 2: 757–762, 1982PubMedCrossRefGoogle Scholar
  16. Hussey KP. Vasopressin therapy for upper gastrointestinal tract hemorrhage. Archives of Internal Medicine 145: 1263–1267, 1985PubMedCrossRefGoogle Scholar
  17. Jenkins SA, Baxter JN, Corbett W, Devitt P, Ware J, et al. A prospective randomized controlled trial, comparing somatostatin and vasopressin for the control of acute variceal haemorrhage. British Medical Journal 290: 275–278, 1985PubMedCrossRefGoogle Scholar
  18. Kim B, Wright HK, Bordan D, Fielding LP, Swaney R. Risks of surgery for upper gastrointestinal hemorrhage: 1972 versus 1982. American Journal of Surgery 149: 474–476, 1985PubMedCrossRefGoogle Scholar
  19. Kittang E, Aadland E, Oyen D, et al. Effect of peroral antacid treatment in patients with acute upper gastrointestinal haemorrhage: a randomized controlled trial. Scandinavian Journal of Gastroenterology 75 (Suppl.): 190–192, 1982Google Scholar
  20. Kravetz D, Bosch J, Bruix J, et al. Comparison of intravenous somatostatin and vasopressin infusions in treatment of acute variceal hemorrhage. Hepatology 4: 442–446, 1984PubMedCrossRefGoogle Scholar
  21. Krejs GJ, Little KH, Westergard H, et al. Laser photocoagulation for the treatment of acute peptic-ulcer bleeding. New England Journal of Medicine 316: 1618–1621, 1987PubMedCrossRefGoogle Scholar
  22. Laine L. Multipolar electrocoagulation in the treatment of active upper gastrointestinal tract hemorrhage. New England Journal of Medicine 316: 1613–1617, 1987PubMedCrossRefGoogle Scholar
  23. Linscheer WG, Fazio TL. Control of upper gastrointestinal hemorrhage by endoscopic spraying of clotting factors. Gastroenterology 77: 642–646, 1979PubMedGoogle Scholar
  24. Londong W, Hasford J, Sander R. Prevention of recurrent bleeding from gastrointestinal ulcers by combined application of cimetidine and pirenzepine: a double-blind, randomized multicenter trial. In Dotevall G. (Ed.) Advances in gastroenterology with the selective antimuscarinic compound pirenzepine, pp. 152–153, Excerpta Medica, Amsterdam, 1982Google Scholar
  25. Magnusson I, Ihre T, Johansson C, et al. Randomized double blind trial of somatostatin in the treatment of massive upper gastrointestinal haemorrhage. Gut 26: 221–226, 1985PubMedCrossRefGoogle Scholar
  26. Marshall M, Bird T. Blood loss and replacement. Edward Arnold, London, 1983Google Scholar
  27. Panes J, Viver J, Forne M, et al. Controlled trial of endoscopic sclerosis in bleeding peptic ulcers. Lancet 2: 1292–1294, 1987PubMedCrossRefGoogle Scholar
  28. Peura DA, Johnson LF, Burkhalter EL, et al. Use of trifluoroisopropyl cyanoacrylic polymer (MBR 4197) in patients with bleeding peptic ulcers of the stomach and duodenum: a randomized controlled study. Journal of Clinical Gastroenterology 4: 325–328, 1982PubMedCrossRefGoogle Scholar
  29. Ponsky JL, Hoffman M, Swayngim DS. Saline irrigation in gastric hemorrhage: the effect of temperature. Journal of Surgical Research 28: 204–205, 1980PubMedCrossRefGoogle Scholar
  30. Provenzale D, Sandier RS, Wood DR, Levinson SL, Frakes JT, et al. Development of a scoring system to predict mortality from upper gastrointestinal bleeding. American Journal of the Medical Sciences 294: 26–32, 1987PubMedCrossRefGoogle Scholar
  31. Raskin JB, Camara DS, Levine K. Effect of 15(R)-15-methyl prostaglandin E2on acute upper gastrointestinal hemorrhage. Abstract. Gastroenterology 88: 1550, 1985Google Scholar
  32. Rudolph JP. Automated gastric lavage and a comparison of 0.9% normal saline solution and tap water irrigant. Annals of Emergency Medicine 14(12): 1156–1159, 1985PubMedCrossRefGoogle Scholar
  33. Silverstein FE, Gilbert DA, Tedesco FJ, et al. The National ASGE survey on upper gastrointestinal bleeding. II. Clinical prognostic factors. Gastrointestinal Endoscopy 27: 80–93, 1981Google Scholar
  34. Soehendra N, Grimm H, Nam VC, Berger B. N-Butyl-2-cyanoacrylate: a supplement to endoscopic sclerotherapy. Endoscopy 19: 221–224, 1987PubMedCrossRefGoogle Scholar
  35. Somerville KW, Henry DA, Davies JG, Hine KR, et al. Somatostatin in treatment of haematemesis and melaena. Lancet 1: 130–132, 1985PubMedCrossRefGoogle Scholar
  36. Torres AJ, Landa I, Hernandez F, Jover JM, et al. Somatostatin in the treatment of severe upper gastrointestinal bleeding: a multicentre controlled trial. British Journal of Surgery 73: 786–789, 1986PubMedCrossRefGoogle Scholar
  37. van Essen HA, van Blankenstein M, Wilson JHP, Van Den Berg B, Bruining HA. Intragastric prostaglandin E2and the prevention of gastrointestinal hemorrhage in ICU patients. Critical Care Medicine 13: 957–960, 1985PubMedCrossRefGoogle Scholar
  38. Waterman NG, Walker JL. The effect of gastric cooling on hemostasis. Surgery, Gynecology and Obstetrics 137: 80–82, 1973PubMedGoogle Scholar
  39. Zuckerman G, Welch R, Douglas A, et al. Controlled trial of medical therapy for active upper gastrointestinal bleeding and prevention of bleeding. American Journal of Medicine 76: 361–366, 1984PubMedCrossRefGoogle Scholar

Copyright information

© ADIS Press Limited 1989

Authors and Affiliations

  • John A. Schaffner
    • 1
  1. 1.Rush-Presbyterian-St Lukes Medical CenterChicagoUSA

Personalised recommendations